Joseph Loscalzo is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Brigham And Womens Hospital Department Of Medicine
Boston, MA 02115
Telephone
617-732-6340Registry record last updated 9 Aug 2012.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ionis Pharmaceuticals, Inc.Program year202513 payments$903,929openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20253 payments$21,242openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.8%Calcium channel blocker24.8%Amlodipine Besylate70%Diltiazem 24hr Er (Cd)30%Part D<11 patientsStatin20.1%Atorvastatin Calcium60%Pravastatin Sodium40%Part D<11 patients+ 2 more classes in this area
Blood & clotting
14.8%Factor Xa inhibitor14.8%Eliquis100%Part D<11 patientsRespiratory
8.1%Leukotriene Receptor Antagonist8.1%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
17 NIH research awards on record, funded 1988–2026 per NIH RePORTER. The latest:
- Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells
Brigham and Women'S Hospital
FY2026$682,004R01HL166137 - L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia
Brigham and Women'S Hospital
FY2026$675,979R01HL155107 - Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells
Brigham and Women'S Hospital
FY2025$695,923R01HL166137
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”